Go to main contents

NIH Leadership

UPDATE
2023-11-24
SHARE 링크연결 공유 인쇄

Deputy Minister, National Institute of Health

Deputy Minister, National Institute of Health Park, Hyun-Young

Deputy Minister,
National Institute of Health Park, Hyun-Young.

Education
  • Bacelor of Medicine, Yonsei University, College of Medicine, Korea
  • Master of Medicine, Yonsei University, College of Medicine, Korea
  • Doctor of Medicine, Yonsei University, College of Medicine, Korea
Career
  • Assistant professor, Cardiovascular Research Institute
  • Director, Division of Cardiovascular and Rare disease, Center for Biomedical Sciences, KNIH
  • Director, Division of Cardiovascular, Center for Biomedical Sciences, KNIH
  • Leader, Research team to respond to fine dust diseases, KCDC
  • Leader, Patient information management team, KCDC headquarters
  • Leader, Promotion team of National Center for Medical Information and Knowledge
  • Leader, Clinical Research Support TF
  • Clinical Research Benefit Evaluation Committee, Ministry of Health and Welfare
  • Management Council, National Forensic Service
  • Patient-centered medical technology optimization research project
  • Director, Department of Precision Medicine
  • Chief, National Biobank of Korea

Major Research Field

  • Clinical mechanics & Genome
  • Precision medicine
  • Cardiovascular disease
  • Women's health

Performance

  • Use of Menstrual Sanitary Products in Women of Reproductive Age: Korea Nurses' Health Study(Osong Public Health Res Perspect, 2021)
  • Evaluation of menopausal hormone therapy use in Korea (2002-2013): A nationwide cohort study. (Maturitas, 2021)
  • The Korean Pregnancy Outcome Study (KPOS): Study Design and Participants(J Epidemiol, 2021) and 178 others

Message

.

Director General, Department of Research Planning and Coordination

Director General, Department of Research Planning and Coordination, Lee, Sang-hee

Director General,
Department of Research Planning
and Coordination Lee, Sang-hee.

Education
  • Department of sociology, Sungkyunkwan University
  • Department of Health Administration , Inje University Graduate School
  • Master's degree in health science
Career
  • Director, Division of General Services Division, Ministry of Health and Welfare
  • Director, Division of Health Insurance Assessment, Ministry of Health and Welfare
  • Director, Group of Community Service Reform Promotion, Ministry of the Interior and Safety
  • Director, Division of Senior Policy, Ministry of Health and Welfare
  • Director, Division of Social Services Resources, Ministry of Health and Welfare
  • Director, Division of Long-term Care Insurance Management, Ministry of Health and Welfare
  • Director, Division for Employment of the Disabled, Ministry of Employment and Labor
  • Director, Division of Services for Persons with Disabilities, Ministry of Health and Welfare
  • Director, Division of basic old-age pension, Ministry of Health and Welfare
  • Director, Division of Senior Support, Ministry of Health and Welfare
  • Team leader, Team of Pension Benefit
  • Head, Group of Basic Security Management Division

Major Research Field

  • Policy for the elderly
  • Health insurance

Performance

  • pilot project for the welfare delivery system for the elderly(Hwaseong, Chuncheon)
  • Reorganization of Health Insurance Appropriateness Evaluation Plan

Message

It will strengthen R&D planning functions in the health care sector and enhance cooperation functions with industries, academia, research institutes, and hospitals to enhance the national role for the development of health care R&D in Korea.

Director General, Department of Precision Medicine

Acting Director General, Department of Precision Medicine, Jeong, youngki

Director General,
Department of Precision Medicine Jeong, youngki.

Education
  • -
  • -
  • -
Career
  • -
  • -

Major Research Field

  • -

Performance

  • -

Message

.

Director General, Department of Chronic Disease Convergence Research

Director General, Department of Chronic Disease Convergence Research Kim, Won-ho

Acting Director General,
Department of Chronic Disease
Convergence Research Kim, Won-ho.

Education
  • -
  • -
  • -
Career
  • -
  • -

Major Research Field

  • -

Performance

  • -

Director, National Institute of Infectious Disease

Director, National Institute of Infectious Disease Jang, Hee-chang

Director,
National Institute of Infectious Disease Jang, Hee-chang.

Education
  • Seoul National University College of Medicine(Department of Medicine)
  • Postdoc. fellowship, Department of Medicine Harvard Medical School, Massachusetts General Hospital(Division of infection diseases), USA
Career
  • Resident, Fellow, Seoul National University Hospital
  • International Cooperation Doctor, Korea International Cooperation Agency(KOICA) (Bangladesh)
  • Committee member, the National Examination for Medical Practitioners
  • Vaccination committee, Korea Centers for Disease Control and Prevention(KCDC)
  • Professor, Chonnam National University School of Medicine (Infectious Diseases)
  • Chairman, the Institutional Review Board(IRB), KDCA

Major Research Field

  • Antibiotic resistance
  • Antibiotic therapy
  • Emerging infectious diseases
  • Vaccines

Performance

  • Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis. 2009 Aug 1;49(3):395-401.
  • A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers. Vaccine. 2010 Aug 16;28(36):5845-9.
  • Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin Am J Infect Control. 2017 Jun 1;45(6):667-672. 3 other cases

Director General, Center for Emerging Virus Research

Director General, Center for Emerging Virus Research, Lee, Joo-yeon

Director General,
Center for Emerging Virus Research Lee, Joo-yeon.

Education
  • Doctor of Science
Career
  • Director, Division of Emerging Disease and Vector Research, KCDC
  • Leader, Promotion team for developing treatments, KCDC headquaters

Major Research Field

  • A study on the development of control technologies such as diagnosis, treatment, and immunity of new, variant, and acute viral infectious diseases such as COVID-19, influenza, and SFTS.

Performance

  • Published, The J2N-k hamster model simulates a severe SARS-CoV-2 infection in patients with cardiovascular diseases. (2022, J Virol Methods.)
  • Published, Persistence of the neutralising antibody response after SARS-CoV-2 infection. (2021, Clin Microbiol Infect.) etc.
  • Patent, Transgenic mouse expressing human DPP4 gene susceptible for South Korean strain Middle East respiratory syndrome coronavirus infection and use thereof(2021). etc.

Message

Center for Emerging Virus Research is developing treatments and control technologies for acute and chronic virus infectious diseases such as COVID-19, influenza, and AIDS, and strengthening the foundation for life cycle research through clinical brokerage research.

Director General, Center for Infectious Disease Research

Director General, Center for Infectious Disease Research, Chung, Gyeong-tae

Director General,
Center for Infectious Disease Research Chung, Gyeong-tae.

Education
  • Bachelor of Science, Chung Ang University, Department of biology
  • Master of Science, Chung Ang University College of Medicine, Department of Microbiology
  • Doctor of Science, Chung Ang University College of Medicine, Department of Microbiology
Career
  • Kyoto Prefectural University of Medicine
  • OSAKA University of Medicine
  • Johns Hopkins School of Medicine
  • Thomas Jefferson University of medicine
  • Health Protection England
  • Director, Division of Waterborne diseases, KCDC
  • Director, Division of microorganism, MFDS
  • Director, Division of Vaccine research, KCDC

Major Research Field

  • Tuberculosis
  • Antibiotic Resistance
  • Bacterial infectious disease such as zoonosis
  • Development of core technologies for diagnosis, treatment, and infection control
  • Support for the development of new technologies based on clinical linkage

Performance

  • Published, Development of an attenuated smallpox vaccine candidate: The KVAC103 strain (2021, Vaccine)
  • Published, Optimization of Zika DNA vaccine by delivery systems (2021, Vaccine) and 10 others
  • Patent, RECOMBINANT ANTIGEN DERIVED FROM ZIKA VIRUS E PROTEIN AND USE THEREOF(2018) and 3 others

Message

In september 2020, with the opening of National Institute of Infectious Diseases (NIID), Center for Infectious Disease Research will be in charge of bacterial infectious diseases and will contribute to the improvement of public health by expanding and reorganizing the entire cycle of research and support.

Director General, Center for Vaccine Research

Director General, Center for Vaccine Research, Gi-eun Rhie

Director General,
Center for Vaccine Research Gi-eun Rhie.

Education
  • Seoul National University, Bachelor’s Degree (Department of Microbiology)
  • Seoul National University, Master’s Degree (Department of Microbiology)
  • Brown University, PhD, (Molecular Biology, Cell Biology & Biochemistry(MCB))
Career
  • Director, Division of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, KDCA
  • Director, Division of Pathogen Defense Research, Center for Infectious Disease, KNIH
  • Senior scientist, Division of Bacterial Diseases, KNIH
  • International Vaccine Institute Dispatch

    Research Fellowship, Harvard Medical School

  • Researcher Fellow, Seoul National University College of Medicine
  • Post-Doctoral Researcher, Brown University

Major Research Field

  • Development of anthrax and cholera vaccines, related basic research
  • National Vaccine Research and Development Plan etc.

Performance

  • Construction of a bivalent vaccine against anthrax and smallpox using the attenuated vaccinia virus KVAC103(2021) BMC Microbiology. 21:76
  • Evaluation of the Protective Efficacy of Recombinant Protective Antigen Vaccine (GC1109)-Immunized Human Sera Using Passive Immunization in a Mouse Model (2020) Vaccine 38. 1586-1588
  • Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study (2019) Vaccine 37. 3820-3824 and 78 others
KOGL, Korea Open Government License, BY, NC, NDType 4 : Source Indication - Commercial Use Prohibition - Change Prohibition The works of the Ministry of Science and ICT can be used under the terms of "KOGL Type 4".
connect